Episodes

  • Why We Prefer Control Over Fame
    Jun 28 2026

    Visibility is seductive, but it's a poor substitute for ownership. In this episode of HoldCo, the case is made that the decision to prioritize control over fame isn't a personality preference — it's a strategic and financial one. Drawing from the HoldCo article on choosing control over fame, the episode dismantles the glamour of public recognition and makes a detailed argument for why operational discipline, decision rights, and quiet systems outperform the spotlight over any meaningful time horizon.

    Here's what the episode covers:

    • Fame vs. control as compounding forces: Fame behaves like a sugar rush — fast to spike, fast to fade. Control behaves like compound interest, slowly improving every cycle it runs through.
    • How fame distorts organizational incentives: When visibility becomes a goal, teams optimize for impressions over impact, announcements over execution, and perception management over actual fundamentals.
    • Decision rights as an interest rate on time: The faster the right people can say yes inside the room where work happens, the more operating cycles a company can run — and that difference becomes enormous at scale.
    • Systems over spotlights: Results that flow from well-designed systems survive personnel changes and market shocks; results that flow from personalities leave the company fragile and nervous.
    • Control as a talent and culture advantage: High-caliber people want context, autonomy, and the sense that their craft matters. Control creates the conditions for that — and makes the recruiting pitch almost embarrassingly simple.
    • Capital allocation clarity: When a company isn't renting its patience from an audience with a short attention span, it can stage investments to match evidence, delay what doesn't pull its weight, and overinvest in compounding edges.

    The episode closes with a clean heuristic: choose the option that improves your next ten decisions, not your next ten minutes of attention. Decisions compound. Impressions evaporate. For more on deal-making and strategic momentum, check out the episode JPM Healthcare: Mega-Deals, M&A Fever, and the ACA's Quiet Exit.

    Hold

    Show More Show Less
    8 mins
  • JPM Healthcare: Mega-Deals, M&A Fever, and the ACA's Quiet Exit
    Jun 27 2026

    The 37th Annual J.P. Morgan Healthcare Conference arrived in January 2019 with an unusually loud bang — two blockbuster acquisitions announced before the conference even opened its doors. This episode of HoldCo draws on the full JPM Healthcare deal and conference analysis to break down what the event revealed about where healthcare M&A, regulatory policy, and care delivery were all heading at the start of that year.

    Here's what the episode covers:

    • Bristol-Myers Squibb's $74B Celgene acquisition — announced January 3rd, it instantly ranked among the largest healthcare deals in history and signaled that big pharma was playing offense in 2019.
    • Eli Lilly's $8B move on Loxo Oncology — a 68% premium bet on precision oncology science targeting oncogenic drivers, notable even in a week dominated by a far larger deal.
    • FDA Commissioner Scott Gottlieb's agenda — a new office to streamline drug review and a push for generic drug competition, both framed as structural solutions to the drug-pricing problem.
    • CVS Health's post-Aetna vision — CEO Larry Merlo outlined a pivot toward "health hub" concept stores and data-driven pharmacy staff, making the case that the Aetna integration was a long-term care delivery play, not just a financial one.
    • Sage Therapeutics' 43% single-day stock jump — postpartum depression data that surprised the conference floor and illustrated just how much investor appetite existed for breakthroughs in underfunded therapeutic areas.
    • The ACA's conspicuous absence — after years as a dominant conference theme, the Affordable Care Act was barely discussed in 2019, reflecting a sector-wide decision to stop waiting on Washington and drive consolidation from within.

    The episode also examines the revenue cycle management trends spotlighted by Intermountain Healthcare and Mercy Health — including Ensemble Health Partners' nine-fold EBITDA growth in two years — and puts the macro M&A picture in context: a Capital One survey found 44% of respondents named M&A as their top growth strategy heading into 2019, with loan-backed healthcare deals totaling $32.2 billion in 2018 alone. For more from the show, check out the episode Your AI Acquisition Just Inherited 20,000 GDPR Violations, which explores the hidden compliance risks that surface when deals close fast.

    Investment Bank

    Show More Show Less
    8 mins
  • Your AI Acquisition Just Inherited 20,000 GDPR Violations
    Jun 26 2026

    AI acquisitions are among the most exciting deals in today's market — and among the most legally treacherous. When a buyer closes on an AI company, they inherit not just the model and the talent, but the full data lineage that trained it: every sourcing decision, every lapsed consent framework, every forgotten database. This episode of HoldCo examines the hidden GDPR exposure in AI acquisitions and makes the case that privacy due diligence has moved from back-office checkbox to deal-critical discipline.

    The episode walks through how GDPR liability accumulates inside an AI company long before any acquisition is on the table — and why it becomes the buyer's problem the moment the deal closes. Key topics covered include:

    • What you actually acquire: Beyond the algorithm and the team, buyers take on the entire data history that trained the model — including liabilities the sellers may not even know exist.
    • The penalty math: GDPR fines scale with the acquiring company's global revenue, not the target's, meaning a mid-market buyer can face eight-figure exposure for decisions made years before they owned anything.
    • Four places violations hide: Improperly anonymized datasets, legacy data graveyards from earlier product iterations, tainted third-party training data, and derived personal data generated by the model itself.
    • Why "anonymized" isn't a safe harbor: Re-identification through auxiliary data is increasingly feasible, and regulators assess real-world reversibility — not the label a data team applied years ago.
    • The pre-close playbook: Tracing model lineage, auditing vendor contracts for data provenance and indemnification, and asking uncomfortable questions about retention schedules before — not after — signing.
    • Post-close remediation: When issues surface after closing, the episode outlines the priority sequence: halt non-compliant processing, engage privacy counsel, and consider proactive regulator disclosure — which consistently produces better outcomes than regulators discovering problems independently.

    The episode also addresses the cultural friction that emerges when a compliance-mature acquirer integrates a startup team accustomed to moving fast, and looks ahead to how the EU AI Act will layer additional requirements on top of existing GDPR obligations — raising the stakes further for future AI deals.

    For more on how operational and compliance considerations shape acquisition strategy, listen to Why We Rarely Touch Marketing First, another episode from the HoldCo feed. More due diligence frameworks and analysis of risk in tech transactions are available at Mergers & Acquisitions.

    Mergers & Acquisitions

    Show More Show Less
    9 mins
  • Why We Rarely Touch Marketing First
    Jun 25 2026

    Marketing is one of the most tempting places to start when building or acquiring a business — it's visible, energizing, and feels like momentum. But the HoldCo team has found, repeatedly, that reaching for campaigns and ad budgets before the fundamentals are solid doesn't just waste money; it actively makes the underlying problems harder to solve. This episode unpacks the reasoning behind their discipline, drawing on the thinking laid out in the HoldCo article on skipping marketing first.

    The episode walks through the four-part sequence HoldCo works through before any marketing budget is opened, and explains why sequencing matters more than speed:

    • Problem and promise clarity: Pinning down a single, plain-language sentence that a skeptical buyer would nod at — not shrug at — before any headline is written.
    • Unit economics as the gatekeeper: Modeling acquisition cost, churn, and contribution margin under conservative assumptions, because marketing can't rescue a product whose math only works on a lucky day.
    • A product genuinely worth recommending: Using word-of-mouth not as a growth strategy, but as a diagnostic — if customers wouldn't refer without a bribe, the job isn't finished.
    • Operations built to handle growth: Stress-testing capacity and delivery before demand scales, because a pattern of broken promises undoes everything marketing builds.
    • Distribution before advertising: Prioritizing owned and earned reach — partnerships, referral loops, content — so that paid media becomes a booster rather than a lifeline.
    • Pricing as a trust signal: Treating price structure as a strategic message about quality and commitment, not a placeholder to be negotiated away in every ad click.

    The episode closes with a useful reframe: patience isn't procrastination. When the right problems are fixed in the right order, marketing becomes a tool rather than a gamble — campaigns cost less, sales cycles shorten, and the compounding effect of owned channels drives long-term valuation in ways that rented attention never can. For more from the show, check out the earlier episode Commercial Real Estate in 2016: Rates, Foreign Capital, and the Oil Wild Card, which examines another domain where sequencing and macro awareness shape smart capital decisions.

    Hold

    Show More Show Less
    7 mins
  • The Great Agency Divide: Inside Ad & Marketing M&A Right Now
    Jun 25 2026

    The advertising and marketing services sector recorded over 2,300 transactions in 2024 — a 12% year-over-year increase — yet that headline figure masks a far more nuanced reality. Drawing on this in-depth analysis of advertising and marketing M&A, this episode of HoldCo unpacks the structural bifurcation reshaping how agencies are bought, sold, and valued right now. Whether you're a founder considering an exit or an operator trying to understand where the market is heading, the data paints a clear picture: buyer appetite is strong, but it is also sharply concentrated.

    The episode covers what's actually driving deal activity, who is acquiring whom, what multiples look like across different agency types, and what separates a premium exit from an average one:

    • A market splitting in two: Scaled, tech-enabled, performance-focused agencies are attracting competitive bids at premium valuations, while traditional, labor-intensive agency models face pricing pressure and a shrinking acquirer pool.
    • Budget rotation, not budget cuts: Total ad spend hasn't disappeared — it's migrating rapidly toward performance marketing, commerce and retail media, influencer channels, and lifecycle CRM, where outcomes are directly measurable.
    • AI as both catalyst and threat: Buyers are actively hunting for agencies with proprietary data, AI-native workflows, or automation IP; for everyone else, AI is compressing what clients will pay for commodity creative and media work.
    • The valuation gap is real: Generalist SMB agencies are transacting in mid-single-digit EBITDA multiples, while performance, commerce, data, and AI-specialist assets are commanding high single to low double-digit multiples — with CX digital transformation peers trading at 13–14× on public markets.
    • Strategics dominate, PE refocuses: Strategic buyers accounted for roughly 67% of 2024 transactions; private equity, constrained by financing costs, shifted toward add-on acquisitions, with 40+ PE-backed platforms running active roll-up strategies in digitally native agencies.
    • The mega-deal reshaping the top of the market: Omnicom's ~$13B acquisition of Interpublic — creating the world's largest agency group — signals how aggressively holding companies are repositioning around data, media, and AI infrastructure.

    The episode closes with a clear framework for sellers and acquirers alike: the agencies achieving the best outcomes today share recurring or performance-based revenue, some form of proprietary data or workflow advantage, organic growth in channels buyers prioritize, and a credible AI story. The structural rotation toward measurable, outcome-linked marketing is accelerating — and M&A pricing already reflects it. For more from the show, check out The 1031 Exchange: How Real Estate Investors Legally Defer Capital Gains, which explores another high-stakes financial decision that rewards careful timing and structure.

    Mergers & Acquisitions

    Show More Show Less
    10 mins
  • Commercial Real Estate in 2016: Rates, Foreign Capital, and the Oil Wild Card
    Jun 24 2026

    Commercial real estate had pulled off one of the more remarkable recoveries in recent economic memory by the time 2016 arrived — clawing back from price declines of nearly forty percent to become a magnet for global capital. This episode of HoldCo draws on a 2016 commercial real estate outlook from Investment Bank to unpack the three macro forces — interest rates, foreign investment, and oil prices — that were simultaneously driving opportunity and introducing new layers of risk across the sector.

    The episode walks through each force in detail, exploring how they interact with property values, cap rates, lending behavior, and investor geography. Key topics covered include:

    • The recovery in context: After bottoming out post-financial crisis, the commercial real estate industry was projecting nearly $923 billion in revenue for 2016, supported by steady annual growth since 2011.
    • The Federal Reserve's rate hike and its ripple effects: The December 2015 rate increase — the first in nearly seven years — set off a chain reaction in how investors price commercial properties, with rising Treasury yields pushing cap rates up and potentially compressing valuations in debt-dependent top-tier markets.
    • The negative rate wild card: With the Fed not having ruled out negative interest rates at the time, the episode examines what genuinely uncharted monetary territory could mean for an asset class that depends so heavily on predictable borrowing costs.
    • The foreign capital explosion: Cross-border purchases of U.S. commercial real estate surged from $4.7 billion in 2009 to $78.4 billion in 2015 — partly unleashed by the rollback of FIRPTA — with investors from Canada, Norway, Singapore, and China moving beyond gateway cities into secondary and tertiary markets.
    • Why the U.S. looked so attractive globally: Currency instability in China, political volatility in the Middle East, and economic turmoil in South America made U.S. commercial real estate stand out as a liquid, transparent, and politically stable destination for capital.
    • Oil's double-edged impact: Falling energy prices created real headwinds for energy-dependent markets in Texas, Colorado, and the Midwest, while delivering a modest tailwind to the broader national market through lower business costs and stronger consumer spending.

    The broader takeaway the episode drives home is that commercial real estate cannot be understood in isolation — monetary policy, tax law, geopolitics, and commodity prices all find their way into cap rates and property valuations eventually. For more on how market dynamics can mislead even experienced investors, check out the HoldCo episode Why "Founder-Friendly" Should Set Off Alarms.

    Investment Bank
    RealEstateInvestor.net

    Show More Show Less
    7 mins
  • Why "Founder-Friendly" Should Set Off Alarms
    Jun 23 2026

    Few phrases in venture and private equity travel as far on as little substance as "founder-friendly." In this episode of HoldCo, the team digs into the skeptical case against founder-friendly deal rhetoric — arguing that warm language in a pitch deck is no substitute for clean mechanics in the actual documents. Understanding the gap between the two is where founders protect themselves.

    The episode walks through the anatomy of deals that sound generous but aren't, covering:

    • Why "founder-friendly" is a vibe, not a standard — soft framing can't override hard definitions buried in side letters and clause language.
    • Where control actually hides — board seat composition, protective provisions, and consent rights are the real levers of power, not the headline terms.
    • How liquidation preferences and anti-dilution clauses reshape exits — a one-times non-participating preference is a safety belt; stacked, participating structures can turn a fair-looking exit deeply lopsided.
    • The timing mismatch problem — investor fund horizons and founder learning curves rarely align naturally, and impatient capital converts governance rights into speed brakes the moment growth zigs instead of rockets.
    • The valuation trap — a flattering entry price narrows the corridor for future rounds, employee grants, and strategic pivots, often leaving founders with a trophy number and reduced maneuverability.
    • A practical diligence framework — running conservative, base, and strong scenarios through the proposed structure, and asking three pointed questions about flat rounds, decision rights, and expected traction timelines.

    The core argument is simple: a deal is only as friendly as it behaves when the wind shifts. Genuinely founder-respecting structures present plain economics, limited preferences, time horizons that match the actual work, and documents that say what the conversation said. Red flags — adjectives up front, definitions avoided, preferences that multiply when the PDF arrives — aren't paranoia triggers; they're pattern recognition. The episode closes with a reminder that good partners don't need to sell their virtue. They design for clarity and let you turn the rug over.

    For more from the show, check out the episode on The 1031 Exchange: How Real Estate Investors Legally Defer Capital Gains. More frameworks and longer-form thinking live at the

    Holding company

    Show More Show Less
    8 mins
  • The 1031 Exchange: How Real Estate Investors Legally Defer Capital Gains
    Jun 21 2026

    For long-term real estate investors, few tax strategies carry more wealth-building potential than the 1031 exchange — yet it remains widely misunderstood and frequently misapplied. This episode of HoldCo draws on this in-depth guide to the 1031 exchange and capital gains deferral to explain how the mechanism works, who it's built for, and what it takes to execute one without triggering the very tax bill you're trying to defer.

    The episode covers the full landscape of the strategy, from foundational concepts to the procedural mechanics that determine whether an exchange succeeds or fails:

    • What a 1031 exchange actually does: It defers — not eliminates — capital gains tax when an investor swaps one qualifying investment property for another, keeping more capital compounding in the next deal.
    • The "like-kind" myth: The requirement is far broader than most investors assume — a commercial warehouse can be exchanged for a residential rental, or raw land for a retail property, as long as both are held for investment or productive business use.
    • Four types of exchanges: The delayed exchange (most common, up to 180 days to close), the simultaneous swap, the reverse exchange (replacement property acquired first, requires substantial liquidity), and the construction/improvement exchange for when the replacement property costs less than the one being sold.
    • The role of the Qualified Intermediary: A QI is not optional — the IRS mandates one, and if sale proceeds ever touch the investor's hands directly, the exchange is immediately disqualified and the full gain becomes taxable.
    • The deadlines that sink deals: From the closing date of the relinquished property, investors have exactly 45 days to identify a replacement property in writing, and 180 days (running concurrently, not consecutively) to close on it — with zero exceptions.
    • Why professional guidance is non-negotiable: Between QI selection, IRS Form 8824, state-level filing requirements, and the precision required in purchase agreements, this is not a strategy to navigate without an experienced tax attorney, CPA, or advisory team.

    For investors weighing a real estate sale and wondering whether a 1031 exchange fits their situation, this episode offers a clear-eyed framework for understanding the opportunity — and the discipline required to capture it. If you enjoyed this episode, you might also want to listen to How Long Does a Deal Really Take? The Truth About M&A Timelines for more on what the execution side of complex transactions actually looks like.

    Investment Bank

    Show More Show Less
    7 mins